NYSE:GSK - GlaxoSmithKline plc
$40.44
 $0.07
+0.17%
12:00PM EDT
2019-08-20
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines, vaccines and consumer healthcare products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health categories. Its product portfolio includes Adartrel, Bexsero, Daraprim and Quinvaxem. Its brands include Panadol, abreva, polident and physiogel. Read more at  reuters.com
sector:  health care
industry:  pharmaceuticals
the data below are updated and published after 9pm EDT each trading day
  GSK     avg for
industry  
  avg for
sector  
42 stocks weight:  107. 00   0. 00   0. 00  
42 stocks rank:  1. 39 K 877. 02   778. 64  
# analyst opinions:  3. 00   10. 23   13. 18  
mean recommendation:  2. 00   2. 06   2. 08  

quick ratio:  0. 44   1. 43   1. 96  
current ratio:  0. 71   1. 92   2. 49  

ex-dividend date:     2019-08-07
dividend rate:  1. 86   1. 90   1. 63  
dividend yield:  4. 65 % 2. 64 % 1. 88 %
target price low:  45. 00   77. 89   109. 70  
target price avg:  45. 33   89. 41   132. 00  
target price high:  46. 00   100. 50   149. 83  
1-yr high:  42. 18   87. 99   135. 15  
last close:  40. 37   78. 98   117. 91  
50-day avg:  40. 70   79. 33   117. 98  
200-day avg:  40. 04   77. 20   114. 34  
1-yr low:  37. 07   66. 07   94. 47  
volume:  1. 37 M 5. 93 M 3. 86 M
50-day avg volume:  2. 34 M 6. 54 M 4. 23 M
200-day avg volume:  2. 87 M 7. 30 M 4. 70 M

1-day return:  0. 45 % 0. 83 % 0. 92 %
this week return:  0. 45 % 0. 83 % 0. 92 %
12-wk return:  4. 48 % 4. 81 % 7. 51 %
52-wk return:  -3. 31 % 4. 81 % 4. 37 %

enterprise value (EV):  99. 43 B 172. 02 B 111. 80 B
market cap:  100. 01 B 161. 27 B 102. 40 B
debt/equity:  1. 13 K 159. 04   141. 66  

shares outstanding:  2. 49 B 2. 28 B 1. 25 B
shares:  2. 44 B 2. 15 B 1. 22 B
shares short:  6. 33 M 19. 85 M 13. 35 M
shares short prior month:  6. 43 M 17. 82 M 11. 95 M
short ratio:  2. 39   3. 37   3. 96  

book value:  2. 41   18. 13   26. 64  
price/book:  16. 78   8. 41   7. 05  
gross profits:  21. 11 B 67. 55 B 35. 86 B
operating margins:  0. 00 % -146. 61 % -116. 32 %
EBITDA margins:  33. 67 % 30. 34 % 24. 13 %
profit margins:  13. 94 % 19. 81 % 14. 46 %
gross margins:  68. 53 % 69. 58 % 57. 94 %

1-yr max volatility:  7. 79 % --- ---
1-yr mean volatility:  0. 77 % 1. 10 % 1. 26 %

1-yr EPS:  0. 99   2. 59   4. 09  
forward EPS:  3. 05   5. 11   6. 68  
P/E:  40. 70   22. 60   23. 47  
forward P/E:  13. 18   15. 50   17. 87  
PE/G:  1. 17   0. 71   -1. 45  
growth:  34. 75 % 46. 81 % 106. 28 %
earnings high:  0. 78   1. 22   1. 62  
earnings avg:  0. 78   1. 15   1. 50  
earnings low:  0. 78   1. 08   1. 40  
revenue high:  10. 35 B 9. 57 B 8. 88 B
revenue avg:  10. 06 B 9. 40 B 8. 72 B
revenue low:  9. 77 B 9. 25 B 8. 54 B
earnings growth:  116. 90 % 43. 02 % 139. 14 %
1-qtr earnings growth:  118. 60 % 92. 20 % 256. 67 %
return on assets:  8. 03 % 6. 89 % 5. 57 %
return on equity:  161. 84 % 28. 33 % 20. 65 %
revenue growth:  6. 80 % 24. 94 % 44. 09 %

beta (1yr vs S&P500):  0. 38   0. 70   0. 89  
sharpe (1yr):  -0. 04   0. 67   0. 58  

held % insiders:  0. 01 % 1. 94 % 3. 43 %
held % institutions:  11. 00 % 55. 49 % 67. 65 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-08-19 : GSK
.    145.149 =         145.149 :: --> INITIAL WEIGHT <--
.    + 0.992 =         146.141 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 0.999 =         145.976 :: P/E factor
.    x 0.995 =         145.181 :: PE/G factor
.    x 1.568 =         227.691 :: beta factor
.    x 0.864 =         196.838 :: sharpe factor
.    x 0.959 =         188.727 :: current ratio factor
.    x 0.921 =         173.783 :: quick ratio factor
.    x 1.241 =         215.688 :: short ratio factor
.    x 1.115 =         240.429 :: return on assets factor
.    x 1.511 =         363.295 :: return on equity factor
.     x 1.66 =         603.243 :: earnings growth factor
.    x 1.101 =         664.021 :: revenue growth factor
.    x 1.151 =         764.435 :: price-to-book factor
.    x 0.879 =         672.083 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.     x 2.88 =        1935.569 :: sector+industry 1-year gains factor
.    x 1.048 =        2028.654 :: industry 12-weeks return factor
.    x 1.311 =         2660.32 :: industry 2-weeks return factor
.    x 1.064 =        2831.364 :: company one-year gains+dividend factor
.    x 2.608 =        7384.856 :: company 13 weeks' performance factor
.    x 1.006 =        7432.699 :: 5-day avg > 200-day avg
.    x 1.016 =        7555.122 :: 50-day avg > 200-day avg
.      x 1.0 =         7552.18 :: "drift" penalty 1 days ago
.    x 0.996 =        7519.219 :: "drift" penalty 2 days ago
.    x 0.959 =        7212.562 :: overall "drift" factor
.    x 0.977 =        7045.783 :: largest single-day price delta factor
.    x 0.999 =        7038.182 :: volatility factor
.    x 0.999 =        7030.425 :: 42-day volatility factor
.    x 4.088 =       28741.415 :: notable returns + performance factor
.    x 2.179 =       62626.879 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 1.304 =       81671.448 :: forward EPS factor
.    x 1.442 =      117734.751 :: forward P/E factor
.    x 1.191 =      140170.429 :: industry recommendation factor
.    x 2.122 =      297374.045 :: company recommendation factor
.    x 1.035 =      307897.888 :: factor historical industry gain for week 33
.     x 1.42 =      437270.042 :: target low factor
.    x 1.117 =      488360.516 :: target mean factor
.    x 1.016 =      496020.267 :: target high factor
.    x 7.668 =     3803336.548 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =          44.161 :: reduced for readability
.   + 62.839 =           107.0 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      107.0 :: FINAL WEIGHT for NYSE:GSK


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org